| Lactate: a metabolic driver in the tumour landscape L Ippolito, A Morandi, E Giannoni, P Chiarugi Trends in biochemical sciences 44 (2), 153-166, 2019 | 308 | 2019 |
| Cancer metabolism in space and time: beyond the Warburg effect P Danhier, P Bański, VL Payen, D Grasso, L Ippolito, P Sonveaux, ... Biochimica et Biophysica Acta (BBA)-Bioenergetics 1858 (8), 556-572, 2017 | 203 | 2017 |
| Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer. EG Luigi Ippolito, Andrea Morandi, Maria Letizia Taddei, Matteo Parri ... Oncogene, 2019 | 190 | 2019 |
| Lactate modulates CD4+ T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis G Comito, A Iscaro, M Bacci, A Morandi, L Ippolito, M Parri, I Montagnani, ... Oncogene 38 (19), 3681-3695, 2019 | 153 | 2019 |
| Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells L Ippolito, A Marini, L Cavallini, A Morandi, L Pietrovito, G Pintus, ... Oncotarget 7 (38), 61890, 2016 | 126 | 2016 |
| Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells ML Taddei, E Giannoni, A Morandi, L Ippolito, M Ramazzotti, M Callari, ... Cell Communication and Signaling 12, 1-12, 2014 | 106 | 2014 |
| Reprogramming of amino acid transporters to support aspartate and glutamate dependency sustains endocrine resistance in breast cancer M Bacci, N Lorito, L Ippolito, M Ramazzotti, S Luti, S Romagnoli, M Parri, ... Cell reports 28 (1), 104-118. e8, 2019 | 79 | 2019 |
| Lactate rewires lipid metabolism and sustains a metabolic–epigenetic axis in prostate cancer L Ippolito, G Comito, M Parri, M Iozzo, A Duatti, F Virgilio, N Lorito, ... Cancer research 82 (7), 1267-1282, 2022 | 56 | 2022 |
| miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer G Barisciano, T Colangelo, V Rosato, L Muccillo, ML Taddei, L Ippolito, ... British journal of cancer 122 (9), 1354-1366, 2020 | 45 | 2020 |
| Nutritional exchanges within tumor microenvironment: impact for cancer aggressiveness G Comito, L Ippolito, P Chiarugi, P Cirri Frontiers in oncology 10, 396, 2020 | 45 | 2020 |
| Mitochondrial redox hubs as promising targets for anticancer therapy L Ippolito, E Giannoni, P Chiarugi, M Parri Frontiers in oncology 10, 256, 2020 | 42 | 2020 |
| Glucose Metabolic Reprogramming of ER+ Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib N Lorito, M Bacci, A Smiriglia, M Mannelli, M Parri, G Comito, L Ippolito, ... Cells 9 (3), 668, 2020 | 25 | 2020 |
| Metabolic cell communication within tumour microenvironment: models, methods and perspectives M Parri, L Ippolito, P Cirri, M Ramazzotti, P Chiarugi Current Opinion in Biotechnology 63, 210-219, 2020 | 9 | 2020 |
| Stromal-induced mitochondrial re-education: Impact on epithelial-to-mesenchymal transition and cancer aggressiveness M Bacci, L Ippolito, L Magnelli, E Giannoni, P Chiarugi Seminars in cell & developmental biology 98, 71-79, 2020 | 7 | 2020 |
| Unconventional roles of lactate along the tumor and immune landscape L Ippolito, P Sonveaux, P Chiarugi Trends in Endocrinology & Metabolism 33 (4), 231-235, 2022 | 4 | 2022 |
| Nutritional and metabolic signalling through GPCRs E Pardella, L Ippolito, E Giannoni, P Chiarugi FEBS letters 596 (18), 2364-2381, 2022 | 3 | 2022 |
| Hypoxia and Hypoxia Inducible Factor (HIF)-1α in Multiple Myeloma: Effect on the Pro-Angiogenic Signature of Myeloma Cells and the Bone Marrow Microenvironment. S Colla, P Storti, G Donofrio, M Lazzaretti, S Bonomini, P Lunghi, ... Blood, The Journal of the American Society of Hematology 112 (11), 1687-1687, 2008 | 3 | 2008 |
| Tumors and their microenvironment P Chiarugi, L Ippolito pH-Interfering Agents as Chemosensitizers in Cancer Therapy, 3-11, 2021 | 2 | 2021 |
| Effect of cimetidine on PRL secretion in elderly subjects. R Volpi, C Davoli, L Ippolito, B Lari, P Chiodera, V Coiro Journal of Endocrinological Investigation 8, 27-27, 1985 | 1 | 1985 |
| Acetyl-CoA carboxylase 1 controls a lipid droplet–peroxisome axis and is a vulnerability of endocrine-resistant ER+ breast cancer M Bacci, N Lorito, A Smiriglia, A Subbiani, F Bonechi, G Comito, ... Science Translational Medicine 16 (736), eadf9874, 2024 | | 2024 |
